Gaudium IVF And Women Health IPO Details
The Gaudium IVF And Women Health IPO is a book build issue with a total issue size of ₹165 cr, comprising of fresh issue of 11392500 equity shares., and a offer for sale of 9493700 equity shares. Gaudium IVF And Women Health IPO opened for subscription on Feb 20, 2026 and closed on Feb 24, 2026. Gaudium IVF And Women Health IPO is set price band at ₹75 to ₹79 per share, with a lot size of 189 shares. Minimum investment for Retail investors was ₹14,931.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Feb 25, 2026, and listed on both the NSE and BSE on Feb 27, 2026.
Bigshare Services Pvt Ltd has been appointed as the registrar. Sarthi Capital Advisors Private Limited are the Book Running Lead Manager for the issue.
Before investing in the Gaudium IVF And Women Health IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 75 – 79
- Lot Size
- 189
- Issue Size
- ₹165 Cr
- Minimum Investment
- ₹14931 (189 Shares)
- Listing Date
- 27 February 2026
Current GMP
₹-4 (-5.06%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Gaudium IVF and Women Health Limited
Gaudium IVF & Women Health Limited is a pan-India fertility and women’s healthcare provider, incorporated in March 2015. The company delivers Assisted Reproductive Technology (ART) services through a scalable hub-and-spoke model, enabling operational efficiency and wider patient reach across India.
Gaudium IVF operates over 30 locations, including seven company-owned hub centres and 28 spoke centres developed through strategic alliances with leading infertility specialists. Its hubs are situated in key urban markets—two in Delhi (Janakpuri and Kailash Colony), and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bengaluru—ensuring strong geographic coverage and accessibility. The company also serves international patients from countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company offers a comprehensive range of fertility treatments, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Frozen Embryo Transfer (FET), ovulation induction, fertility preservation through cryopreservation, and advanced genetic screening such as Preimplantation Genetic Testing (PGT). In addition to reproductive medicine, Gaudium provides integrated gynecological and obstetric services, including treatment for PCOD/PCOS, endometriosis management, high-risk pregnancy care, male infertility treatments, and minimally invasive laparoscopic and hysteroscopic procedures.
A key differentiator of the company is its holistic and patient-centric approach. Beyond clinical treatment, Gaudium IVF integrates fertility wellness programs that include nutritional counseling and psychological support to enhance patient outcomes. As of March 31, 2025, the company had a workforce of 124 employees, including seven consultancy doctors.
Competitive Strengths
- Strong patient-centric care model
- Experienced and specialized medical team
- Advanced laboratory infrastructure, including next-generation INTEGRA Ti labs for ICSI
- Highly technical ultrasound-guided (USG) services
- Strategically located hubs in prime urban centres
- Asset-light and scalable hub-and-spoke operating model
Overall, Gaudium IVF & Women Health Limited combines clinical expertise, advanced reproductive technologies, and a scalable business structure to strengthen its position in India’s growing fertility care market.
Gaudium IVF And Women Health IPO Promoters
- Dr. Manika Khanna
- Dr. Peeyush Khanna
- Vishad Khanna
Promoters Holding
Holding Pre Issue
99.99%
Holding Post Issue
71.30%
Gaudium IVF And Women Health IPO Objective
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Funding capital expenditure towards establishment of New IVF Centers of our Company . : 50.00Cr
- Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company. : 20.00Cr
- General Corporate Purposes
Address / Contact Info
Gaudium IVF & Women Health Limited
B1/51,Janak Puri,B-1,
New Delhi, New Delhi, 110058
Email:compliance@gaudiumivfcentre.com
Telephone: 011- 4885 8585.
Website:http://www.gaudiumivfcentre.com/
IPO Snapshot
Book Running Lead Managers
- Sarthi Capital Advisors Private Limited
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Gaudium IVF And Women Health IPO is a Book-building IPO with a total issue size of ₹165 crore. The Gaudium IVF And Women Health IPO price band is ₹75 to 79 per share. The Gaudium IVF And Women Health IPO subscription opens on Fri, Feb 20, 2026, and closes on Tue, Feb 24, 2026. The Gaudium IVF And Women Health IPO will be listed on the BSE,NSE. Bigshare Services Pvt Ltd is the registrar for the Gaudium IVF And Women Health IPO.
The Gaudium IVF And Women Health IPO opens on Fri, Feb 20, 2026 and closes on Tue, Feb 24, 2026
Gaudium IVF And Women Health IPO Price Band is ₹75 to 79 per share.
Gaudium IVF And Women Health IPO lot size is 189 shares, Retail investors need a minimum investment of ₹14931 based on the upper price band
The minimum investment for Gaudium IVF And Women Health IPO is ₹14931, based on one lot of 189 shares at the upper price band of ₹79 per share.
Investors can apply for the Gaudium IVF And Women Health IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Feb 24, 2026. The application amount remains blocked until the Gaudium IVF And Women Health IPO allotment is finalized.
Gaudium IVF And Women Health IPO issue size is ₹165 crores.
Gaudium IVF And Women Health IPO allotment date is Wed, Jul 1, 2026.
The registrar for Gaudium IVF And Women Health IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Gaudium IVF And Women Health IPO allotment status, refund processing, and other IPO-related information.
The Gaudium IVF And Women Health IPO GMP (Grey Market Premium) is ₹0 as of Fri, Feb 27, 2026. Based on the upper price band of ₹79 per share, the estimated Gaudium IVF And Women Health IPO listing price is ₹79, indicating a potential listing gain of approximately 0% over the issue price.